Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
作者信息
Al Hammadi A M, Sallah S
出版信息
J Thromb Haemost. 2007 Feb;5(2):435-6. doi: 10.1111/j.1538-7836.2007.02353.x.
Abstract
摘要
相似文献
1
Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
J Thromb Haemost. 2007 Feb;5(2):435-6. doi: 10.1111/j.1538-7836.2007.02353.x.
2
The use of recombinant factor VIIa for bleeding in paediatric practice.
Haemophilia. 2005 Mar;11(2):171-4. doi: 10.1111/j.1365-2516.2005.01078.x.
3
The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
J Thromb Haemost. 2003 Mar;1(3):423-4. doi: 10.1046/j.1538-7836.2003.00058.x.
4
Recombinant factor VIIa and trauma: treatment that does not leave you in the cold.
J Thromb Haemost. 2007 Feb;5(2):242-3. doi: 10.1111/j.1538-7836.2007.02367.x. Epub 2006 Dec 14.
5
Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
Semin Hematol. 2001 Oct;38(4 Suppl 12):1-50.
6
More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation.
J Thromb Haemost. 2006 Jan;4(1):288. doi: 10.1111/j.1538-7836.2005.01685.x.
7
Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.
J Thromb Haemost. 2008 Jun;6(6):969-75. doi: 10.1111/j.1538-7836.2008.02954.x. Epub 2008 Mar 21.
8
[Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
Akush Ginekol (Sofiia). 2004;43 Suppl 2:32-5.
9
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Bone Marrow Transplant. 2001 Aug;28(4):405-7. doi: 10.1038/sj.bmt.1703157.
10
Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Pediatr Hematol Oncol. 2003 Sep;20(6):435-8.
引用本文的文献
1
Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.
Int J Mol Sci. 2021 Jan 14;22(2):793. doi: 10.3390/ijms22020793.
2
Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients.
Korean J Pediatr. 2016 Mar;59(3):105-13. doi: 10.3345/kjp.2016.59.3.105. Epub 2016 Mar 31.
3
Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.
J Pediatr Pharmacol Ther. 2012 Jul;17(3):274-80. doi: 10.5863/1551-6776-17.3.274.
Zotero 插件